A detailed history of Bartlett & Co. LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 200 shares of VXRT stock, worth $158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$158
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$4.29 - $6.64 $858 - $1,328
200 New
200 $1,000
Q4 2021

Mar 08, 2022

SELL
$5.77 - $7.96 $1,154 - $1,592
-200 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$5.64 - $23.33 $1,128 - $4,666
200 New
200 $1,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $99.9M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.